Certified B Corporation

Lisboa, Portugal

Certified Since

June 2017


Pharmaceutical products



Operates In




United States

Hovione is an international company with over 61 years of experience as a Contract Development and Manufacturing Organization (CDMO) and is currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. It has sites and offices in Portugal, Ireland, Macau, United States, Hong Kong, India, Japan and Switzerland. The company provides a number of products and services to the pharmaceutical industry including separate or integrated active pharmaceutical ingredients (APIs), pre-formulated compounds, particle engineering, formulation development and manufacturing. Hovione also supports highly potent compounds and proprietary product development and licensing for drug products. It is also present in the inhalation area.

Overall B Impact Score

Based on the B Impact assessment, Hovione earned an overall score of 84.7. The median score for ordinary businesses who complete the assessment is currently 50.9.
84.7 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 8.3

Workers 23.3

Community 14.1

Environment 11.4

Customers 27.4

Previous Overall B Impact Scores

2021 Overall B Impact Score84.7
2017 Overall B Impact Score86.6

Additional Documentation

Hovione Transparent Disclosure 2021

Hovione Score Methodology Summary 2021

Hovione Controversial Industry Statement 2021

Best for the World

Every year, B Lab recognizes the B Corps that have achieved the highest verified scores in the five impact areas evaluated on the B Impact Assessment.

Best For The World: Customers2019
Best For The World: Customers2018

B Labs Logo - Home Link

Sign up to our Insights newsletter, a monthly digest of the latest news on economic systems change from B Lab Global.

We take the security of your data seriously, read our privacy policy for further information. For newsletter communications relating to your local region, please visit Global Partner sites to subscribe.

Copyright © 2023 B Lab. All rights reserved.